Skip to main content

What the FDA labels say about taking them together

Cobicistat and thioridazine

Cobicistat's FDA label of February 10, 2026 names thioridazine in its drug interactions section; the thioridazine label PlainMeds reads does not name cobicistat. The cobicistat label: “A decrease in the dose of antipsychotics that are metabolized by CYP3A or CYP2D6 may be needed upon coadministration.”

Check it at the source: the cobicistat FDA label on DailyMed (effective February 10, 2026, Gilead Sciences, Inc.); the thioridazine FDA label on DailyMed (effective November 11, 2025, Mylan Institutional Inc.).

What does the cobicistat label say about thioridazine?

Cobicistat label, drug interactions

Concomitant Drug Class/Drug Name: Other antipsychotics: e.g., perphenazine risperidone thioridazine; Potential Effect ↑ = Increase, ↓ = Decrease, ↔ = No change: ↑ antipsychotic; Clinical Comment: A decrease in the dose of antipsychotics that are metabolized by CYP3A or CYP2D6 may be needed upon coadministration.

Source: FDA drug label (Tybost), Gilead Sciences, Inc., effective February 10, 2026 (SPL set 3784c35c-e87f-410c-900b-8fd6313c6010), via openFDA; the full label on DailyMed

What does the thioridazine label say about cobicistat?

Thioridazine's label (effective November 11, 2025) does not name cobicistat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Thioridazine Hydrochloride), Mylan Institutional Inc., effective November 11, 2025 (SPL set 52fea941-0b47-41c1-b00d-f88150e8ab93), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Cobicistat generic labelers
5Thioridazine generic labelers
CobicistatThioridazine
Labeled forHIVn/a
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.571 per tablet 25 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?